Hosking Partners’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,167
Closed -$301K 140
2023
Q2
$301K Buy
5,167
+401
+8% +$24.1K 0.01% 137
2023
Q1
$341K Sell
4,766
-890
-16% -$70.6K 0.02% 139
2022
Q4
$398K Sell
5,656
-6,267
-53% -$442K 0.02% 135
2022
Q3
$723K Sell
11,923
-1,254
-10% -$84.1K 0.03% 145
2022
Q2
$832K Sell
13,177
-2,376
-15% -$155K 0.03% 148
2022
Q1
$996K Sell
15,553
-309
-2% -$20.7K 0.03% 144
2021
Q4
$1.14M Sell
15,862
-294
-2% -$22.4K 0.03% 147
2021
Q3
$1.15M Sell
16,156
-1,590
-9% -$125K 0.03% 147
2021
Q2
$1.44M Sell
17,746
-71
-0.4% -$5.71K 0.03% 149
2021
Q1
$1.35M Sell
17,817
-672
-4% -$48.9K 0.03% 150
2020
Q4
$1.4M Sell
18,489
-502
-3% -$32.7K 0.04% 148
2020
Q3
$939K Sell
18,991
-583
-3% -$32.9K 0.03% 155
2020
Q2
$1.03M Sell
19,574
-1,248
-6% -$59.2K 0.03% 154
2020
Q1
$733K Sell
20,822
-534
-3% -$31.2K 0.03% 160
2019
Q4
$1.87M Sell
21,356
-789
-4% -$69K 0.05% 152
2019
Q3
$1.88M Sell
22,145
-1,012
-4% -$90.2K 0.05% 153
2019
Q2
$2.44M Sell
23,157
-278
-1% -$27.9K 0.06% 154
2019
Q1
$2.48M Sell
23,435
-123
-0.5% -$12.4K 0.06% 151
2018
Q4
$1.97M Sell
23,558
-855
-4% -$77.4K 0.06% 156
2018
Q3
$2.49M Sell
24,413
-664
-3% -$64.1K 0.05% 159
2018
Q2
$2.03M Buy
25,077
+177
+0.7% +$14.1K 0.04% 161
2018
Q1
$1.83M Buy
24,900
+1,244
+5% +$93.1K 0.04% 160
2017
Q4
$1.67M Buy
23,656
+1,694
+8% +$122K 0.04% 159
2017
Q3
$1.37M Buy
21,962
+165
+0.8% +$9.77K 0.04% 157
2017
Q2
$1.25M Buy
21,797
+342
+2% +$20.1K 0.03% 157
2017
Q1
$1.31M Buy
21,455
+1,939
+10% +$110K 0.04% 157
2016
Q4
$1.07M Sell
19,516
-478
-2% -$22.9K 0.03% 157
2016
Q3
$922K Sell
19,994
-6,230
-24% -$263K 0.03% 153
2016
Q2
$893K Buy
+26,224
New +$819K 0.04% 149

Other funds holding NGVT

Hosking Partners's NGVT Position: Q3 2023 in Review

Hosking Partners sold out of Ingevity (NGVT) in Q3 2023, closing a stake of 5,167 shares — an estimated $301K sold.

Hosking Partners first reported a position in NGVT in Q2 2016 and held it in 29 quarters. The position peaked at $2.49M in Q3 2018. 258 funds tracked by Wall St. Rank hold NGVT as of Q3 2023.

  • Hosking Partners reported no remaining Ingevity position as of Q3 2023 after selling out during the quarter.
  • Hosking Partners sold 5,167 Ingevity shares in Q3 2023, an estimated $301K.
  • Hosking Partners first reported a position in Ingevity in Q2 2016 and held it in 29 quarters.
  • Hosking Partners's Ingevity position peaked at $2.49M in Q3 2018.
  • 258 funds tracked by Wall St. Rank held Ingevity as of Q3 2023.

Based on Hosking Partners's 13F filing for Q3 2023, filed 8 Nov 2023.